Talis Biomedical Corporat... (TLIS)
1.06
-0.54 (-33.75%)
At close: Apr 04, 2025, 9:37 AM
-33.75% (1D)
| Bid | 1.06 |
| Market Cap | 1.94M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | n/a |
| EPS (ttm) | -28.02 |
| PE Ratio (ttm) | -0.04 |
| Forward PE | -0.07 |
| Analyst | n/a |
| Ask | 1.07 |
| Volume | 1 |
| Avg. Volume (20D) | 1,401 |
| Open | 1.06 |
| Previous Close | 1.60 |
| Day's Range | 1.06 - 1.06 |
| 52-Week Range | 1.04 - 9.60 |
| Beta | 1.47 |
About TLIS
Talis Biomedical Corporation operates as a molecular diagnostic company. The company is developing the Talis One system to address limitations of existing point-of-care diagnostic testing technologies for infectious diseases. It also offers Talis One COVID-19 Test System, which focuses on detection of SARS-CoV-2, the virus that causes COVID-19. In addition, it develops Talis One assay kit for respiratory infections, infections related to women's ...
Industry Medical - Devices
Sector Healthcare
IPO Date Feb 12, 2021
Employees 99
Stock Exchange OTC
Ticker Symbol TLIS
Website https://talisbio.com
8 months ago
-49.33%
Talis Biomedical shares are trading lower after th...
Unlock content with
Pro Subscription
4 months ago · https://www.marketscreener.com
North American Morning Briefing : Global Ad Shares -2-Lundin Mining Announces Sale to Boliden of its Neves-Corvo operation in Portugal and Zinkgruvan operation in Sweden for Up to $1.52 Billion: Lundin To Receive Upfront Cash Consideration of $1.37B Upon...